Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

STAR study will compare raloxifene to tamoxifen for reducing risk of breast cancer

Oct. 26, 1998

Thalidomide designated orphan drug for multiple myeloma

Oct. 26, 1998

Camptosar receives final FDA approval for colorectal cancer

Oct. 26, 1998

Naamidine A identified as EGF receptor antagonist and antiproliferative agent

Oct. 26, 1998

Nonsteroid progesterone antagonists for cancer, gynecological disorders

Oct. 26, 1998

Beta-glucuronidase inhibitors as antitumor/antiinflammatory agents

Oct. 26, 1998

Potent antitumor activity, low toxicity observed in in vitro studies of aplidine

Oct. 23, 1998

Cell Therapeutics initiates phase I lisofylline trial for treatment of mucositis

Oct. 22, 1998

ODAC votes against Warner-Lambert's prostate cancer drug

Oct. 20, 1998

Paclitaxel derivatives useful as antitumor agents prepared at BMS

Oct. 20, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 15, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...